Sector
PharmaceuticalsOpen
₹160.05Prev. Close
₹159.08Turnover(Lac.)
₹746.45Day's High
₹167.98Day's Low
₹155.0552 Week's High
₹28352 Week's Low
₹133Book Value
₹257.55Face Value
₹2Mkt Cap (₹ Cr.)
2,515.11P/E
0EPS
0Divi. Yield
024 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
22 Aug 2023
12:00 AM
AGM
Announcement Date: 22 Aug, 2023
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 31.36 | 31.36 | 31.36 | 31.38 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 4,082.95 | 4,200.42 | 4,643.26 | 4,764.47 |
Net Worth | 4,114.31 | 4,231.78 | 4,674.62 | 4,795.85 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 208.01 | 580.74 | 474.46 | 451.49 |
yoy growth (%) | -64.18 | 22.4 | 5.08 | 6,529.8 |
Raw materials | -108.44 | -200.11 | -155.31 | -142.07 |
As % of sales | 52.13 | 34.45 | 32.73 | 31.46 |
Employee costs | -59.4 | -88.87 | -61.67 | -66.76 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -168.69 | 55.46 | 62.17 | 43.91 |
Depreciation | -143.21 | -140.65 | -134.45 | -135.85 |
Tax paid | -64.12 | -16.94 | -25.1 | -19.67 |
Working capital | 0.78 | 29.87 | 52.04 | 419.05 |
Other operating items |
No Record found
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 2,615.77 | 2,412.92 | 2,140.69 | 1,912.03 | 2,043.6 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,615.77 | 2,412.92 | 2,140.69 | 1,912.03 | 2,043.6 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 28.21 | 27.77 | 43.42 | 38.45 | 44.46 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,587.35 | 124.83 | 3,80,990.4 | 867.6 | 0.85 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,534.8 | 76.42 | 1,20,383.36 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,490 | 32.38 | 1,20,295.96 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,154.55 | 33.79 | 1,16,159.65 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,770.9 | 26.36 | 1,12,931.2 | 1,034.8 | 0.59 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Janmejay R Vyas
Whole-time Director
Deohooti J Vyas
Managing Director & CFO
Arpit J Vyas
Independent Director
Sanjay S Majmudar
Independent Director
Ashok C Gandhi
Independent Director
Subir Kumar Das
Independent Director
Rajendra S Shah
Company Sec. & Compli. Officer
Shrima Dave
Independent Director
Maitri K Mehta
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Dishman Carbogen Amcis Ltd
Summary
Dishman Carbogen Amcis Limited was incorporated in the year July 17, 2007. The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. It has manufacturing and research facilities in India, Switzerland, France, The Netherland and China. As on 31st March 2019, the total number of subsidiaries including step down subsidiaries were 14.During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCLs subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure. The name of Carbogen Amcis (India) Ltd. was changed to Dishman Carbogen Amcis Ltd. with effect from 27 March 2017.Dishman Pharmaceuticals and Chemicals Ltd was incorporated in the year 1983 as a research-oriented organization. The company set up their first manufacturing unit in Naroda for phase Transfer Catalysts. The company earned the status of Quat Company by establishing themselves in the Quat business.In the year 1995, the company formed a joint venture company with Schtz & Co, Germany called as Schutz Dishman Biotech Private Ltd. They manufacture Chlorhexidine Base, Chlorhexidine HCl, Chlorhexidine Acetate and Chlorhexidine Gluconate solution, for the European
Read More
What is the Dishman Carbogen Amcis Ltd share price today?
The Dishman Carbogen Amcis Ltd shares price on N/A is Rs.₹160.45 today.
What is the Market Cap of Dishman Carbogen Amcis Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dishman Carbogen Amcis Ltd is ₹2515.58 Cr. as of 23 Jul ‘24
What is the PE and PB ratio of Dishman Carbogen Amcis Ltd?
The PE and PB ratios of Dishman Carbogen Amcis Ltd is 0 and 0.62 as of 23 Jul ‘24
What is the 52 Week High and Low of Dishman Carbogen Amcis Ltd?
The 52-week high/low is the highest and lowest price at which a Dishman Carbogen Amcis Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dishman Carbogen Amcis Ltd is ₹132.75 and ₹282.95 as of 23 Jul ‘24
What is the CAGR of Dishman Carbogen Amcis Ltd?
Dishman Carbogen Amcis Ltd's CAGR for 5 Years at -5.27%, 3 Years at -9.66%, 1 Year at 3.38%, 6 Month at -16.56%, 3 Month at -31.01% and 1 Month at -8.24%.
What is the shareholding pattern of Dishman Carbogen Amcis Ltd?
The shareholding pattern of Dishman Carbogen Amcis Ltd is as follows:
Promoters - 59.32 %
Institutions - 9.52 %
Public - 31.16 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
